A link to rare blood clots have caused the rollout of the AstraZeneca and Johnson & Johnson Covid-19 vaccines to pause around the world. This is what scientists say about the risks and the next steps.
1upHealth is helping health systems and insurers comply with new federal data sharing rules by standardizing and storing medical and claims information.
In her first interview since being confirmed and sworn-in as assistant secretary of Health and Human Services, the transgender trailblazer talked about Covid-19 vaccines and laws targeting trans youth.
Sajith Wickramasekara was just 24 when he made the Forbes 30 Under 30 list for his biotech R&D startup, Benchling. Now his company is worth $4 billion with a new $200 million round led by Sequoia.
A combination of compounds found in cannabis showed the potential to treat or even prevent coronavirus infections in human lung cells, according to recently published research.
Cirqle Biomedical is a startup pioneering mucus engineering as a new alternative to hormonal birth control, based in Copenhagen, and its team recently demonstrated the first novel and effective approach to contraception since hormonal therapy was introduced more than 60 years ago.
A link to rare blood clots have caused the rollout of the AstraZeneca and Johnson & Johnson Covid-19 vaccines to pause around the world. This is what scientists say about the risks and the next steps.
Data suggests that many Americans remain reluctant to sign up for the shot (or two) that promises a return to life as we used to know it. We need to broaden the influencers to appeal to group affiliations and consider unorthodox incentives based upon principles of behavioral economics.
A CDC online survey indicates that young people between the ages of 18-24 are more likely to suffer mental health problems during the pandemic than any age group.
Now comes a troubling report of the discovery of a new variant from Oregon. As of yet, there are only two confirmed isolates in Oregon with this sequence, but the number of undetected cases is likely larger.
The FDA and CDC announced a pause on the rollout of J&J vaccine out of the old “abundance of caution” following reports of six cases of Cerebral Venous Sinus Thrombosis (CVST). Is this necessary?
While the chance of a blood clot from the J&J vaccine is astronomically low and vaccinating as many people as possible is a paramount goal, the government felt confident it could afford to stop its use.
New York, Connecticut, Massachusetts, New Hampshire, Rhode Island, Maryland, Virginia, Missouri, Georgia, Michigan and Ohio followed a recommendation by federal regulators Tuesday to temporarily pause Johnson & Johnson distribution after six reports of blood clots in vaccine recipients.